| NCT ID | NCT06252038 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Kansas Medical Center |
| Condition | PreDiabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-09-24 |
| Primary Completion | 2028-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2024-09-24 with a primary completion date of 2028-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this randomized controlled trial is to compare the effectiveness of Cooperative Extension implementing two delivery methods (group video vs. self-directed) and participant recruitment strategies of the National Diabetes Prevention Program (NDPP) to adults in rural communities. Exploratory assessments of implementation facilitators and barriers will be completed to determine strategies that may impact intervention effectiveness and that may support or impede the implementation, dissemination, and effectiveness of Cooperative Extension to deliver the NDPP to prediabetic adults in rural areas.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * BMI ≥25 kg/m2, ≥23 kg/m2 if Asian * Blood test results in the pre diabetic range within the last year (HbA1C = 5.7%-6.4% or fasting plasma glucose= 100-125 mg/dl or 2-hr. plasma glucose following a 75-gm glucose load = 140-199 mg/dL) or have previous diagnosis of gestational diabetes or a positive screening for pre diabetes based on CDC pre diabetes risk test * Willing to travel to KSRE site for orientation and outcome testing * Available to attend pre-specified meeting time of GV for their respective KSRE location * Medically stable as deemed by primary care provider consent * English speaking Exclusion Criteria: * Previous diagnosis of Type I or II diabetes * Taking FDA-approved weight loss medications * Primary care provider stating that patient should not participate * Self-report as currently pregnant or within 6 weeks of having given birth (or planning to become pregnant in the next 12 months) * Unable to engage in physical activity
Contact & Investigator
Anna M Gorczyca, PhD
PRINCIPAL INVESTIGATOR
University of Kansas Medical Center
Frequently Asked Questions
Who can join the NCT06252038 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PreDiabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06252038 currently recruiting?
Yes, NCT06252038 is actively recruiting participants. Contact the research team at arice7@kumc.edu for enrollment information.
Where is the NCT06252038 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT06252038 clinical trial?
NCT06252038 is sponsored by University of Kansas Medical Center. The principal investigator is Anna M Gorczyca, PhD at University of Kansas Medical Center. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.